BLTE – Belite Bio Inc ADR
Belite Bio, IncBLTE
$141.42Name : Belite Bio, Inc
Sector : Healthcare
Industry: Biotechnology
Mark. Cap: $5,668,833,792.00
EPSttm : -2.55
Belite Bio, Inc
$141.42
1.28%$1.79
BLTE — Price & Float Short
—— Fair value
★ EPS beat
★ EPS miss
—— Target Price
Float Short %
Float Short %
3.01
Margin Of Safety %
Put/Call OI Ratio
EPS Next Q Diff
-0.14
EPS Last/This Y
-0.97
EPS This/Next Y
4.23
Price
141.77
Target Price
210.5
Analyst Recom
1
Performance Q
-18.72
Upside
-162.6%
Beta
-1.19
Ticker: BLTE
of 1
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2026-05-11 | BLTE | 152.25 | N/A | N/A | 0 |
| 2026-05-12 | BLTE | 156.54 | N/A | N/A | 0 |
| 2026-05-13 | BLTE | 153.81 | N/A | N/A | 0 |
| 2026-05-14 | BLTE | 149.98 | N/A | N/A | 0 |
| 2026-05-15 | BLTE | 142.49 | N/A | N/A | 0 |
| 2026-05-18 | BLTE | 142.32 | N/A | N/A | 0 |
| 2026-05-19 | BLTE | 139.24 | N/A | N/A | 0 |
| 2026-05-20 | BLTE | 143.51 | N/A | N/A | 0 |
| 2026-05-21 | BLTE | 143.92 | N/A | N/A | 0 |
| 2026-05-22 | BLTE | 137.3 | N/A | N/A | 0 |
| 2026-05-26 | BLTE | 142.62 | N/A | N/A | 0 |
| 2026-05-27 | BLTE | 142.84 | N/A | N/A | 0 |
| 2026-05-28 | BLTE | 148.72 | N/A | N/A | 0 |
| 2026-05-29 | BLTE | 145.17 | N/A | N/A | 0 |
| 2026-06-02 | BLTE | 135.43 | N/A | N/A | 0 |
| 2026-06-03 | BLTE | 137.23 | N/A | N/A | 0 |
| 2026-06-04 | BLTE | 145.82 | N/A | N/A | 0 |
| 2026-06-05 | BLTE | 143.4 | N/A | N/A | 0 |
| 2026-06-08 | BLTE | 139.91 | N/A | N/A | 0 |
| 2026-06-09 | BLTE | 141.68 | N/A | N/A | 0 |
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2026-05-11 | BLTE | 152.50 | -42.9 | - | -2.13 |
| 2026-05-12 | BLTE | 156.16 | -42.9 | - | -2.13 |
| 2026-05-13 | BLTE | 153.89 | -42.9 | - | -2.13 |
| 2026-05-14 | BLTE | 150.27 | -42.9 | - | -2.13 |
| 2026-05-15 | BLTE | 142.38 | -42.9 | - | -2.13 |
| 2026-05-18 | BLTE | 142.82 | -42.9 | - | -2.13 |
| 2026-05-19 | BLTE | 139.52 | -42.9 | - | -2.13 |
| 2026-05-20 | BLTE | 143.68 | -42.9 | - | -2.13 |
| 2026-05-21 | BLTE | 143.92 | -42.9 | - | -2.13 |
| 2026-05-22 | BLTE | 137.14 | -42.9 | - | -2.13 |
| 2026-05-26 | BLTE | 141.93 | -62.3 | - | -3.31 |
| 2026-05-27 | BLTE | 142.01 | -62.3 | - | -3.31 |
| 2026-05-28 | BLTE | 148.40 | -62.3 | - | -3.31 |
| 2026-05-29 | BLTE | 144.58 | -62.3 | - | -3.31 |
| 2026-06-01 | BLTE | 147.46 | -54.6 | - | -3.28 |
| 2026-06-02 | BLTE | 135.46 | -54.6 | - | -3.28 |
| 2026-06-03 | BLTE | 137.30 | -54.6 | - | -3.28 |
| 2026-06-04 | BLTE | 144.31 | -54.6 | - | -3.28 |
| 2026-06-05 | BLTE | 143.41 | -54.6 | - | -3.28 |
| 2026-06-08 | BLTE | 140.01 | -54.6 | - | -3.28 |
| 2026-06-09 | BLTE | 141.77 | -54.6 | - | -3.28 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2026-05-11 | BLTE | -8.80 | 5.02 | 2.81 |
| 2026-05-12 | BLTE | -8.80 | 5.02 | 3.11 |
| 2026-05-13 | BLTE | -8.80 | 5.02 | 3.11 |
| 2026-05-14 | BLTE | -8.80 | 5.02 | 3.11 |
| 2026-05-15 | BLTE | -9.40 | 5.02 | 3.11 |
| 2026-05-18 | BLTE | -9.40 | 5.13 | 3.11 |
| 2026-05-19 | BLTE | -9.40 | 5.13 | 3.11 |
| 2026-05-20 | BLTE | -9.40 | 5.13 | 3.11 |
| 2026-05-21 | BLTE | -9.40 | 5.13 | 3.11 |
| 2026-05-22 | BLTE | -9.40 | 5.13 | 3.12 |
| 2026-05-26 | BLTE | -6.13 | 5.63 | 3.12 |
| 2026-05-27 | BLTE | -6.12 | 5.63 | 3.12 |
| 2026-05-28 | BLTE | -6.12 | 5.63 | 3.01 |
| 2026-05-29 | BLTE | -6.12 | 5.63 | 3.01 |
| 2026-06-02 | BLTE | -6.12 | 5.63 | 3.01 |
| 2026-06-03 | BLTE | -6.12 | 5.63 | 3.01 |
| 2026-06-04 | BLTE | -6.12 | 5.63 | 3.01 |
| 2026-06-05 | BLTE | -6.12 | 5.63 | 3.01 |
| 2026-06-08 | BLTE | -6.12 | 5.63 | 3.01 |
| 2026-06-09 | BLTE | -6.12 | 5.63 | 3.01 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
-0.68
Avg. EPS Est. Current Quarter
-0.77
Avg. EPS Est. Next Quarter
-0.82
Insider Transactions
-6.12
Institutional Transactions
5.63
Beta
-1.19
Average Sales Estimate Current Quarter
Average Sales Estimate Next Quarter
Fair Value
Quality Score
14
Growth Score
20
Sentiment Score
58
Actual DrawDown %
29.1
Max Drawdown 5-Year %
Target Price
210.5
P/E
Forward P/E
167.36
PEG
P/S
P/B
7.12
P/Free Cash Flow
EPS
-2.53
Average EPS Est. Cur. Y
-3.28
EPS Next Y. (Est.)
0.94
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
Relative Volume
1.17
Return on Equity vs Sector %
-38.8
Return on Equity vs Industry %
-22.7
EPS 1 7Days Diff
-1.2
EPS 1 30Days Diff
-1.15
EBIT Estimation
◆
BLTE
Healthcare
$141.42
Swing / Pullback
Buy the dip on strong trends
WEAK
RSI
44.4
Range 1M
37.2%
Sup Dist
3.2%
Momentum Growth
Ride accelerating trends
WEAK
EPS Yr
-37.9%
EPS NY
126.5%
52W%
58.8%
Long-Term Value
Quality companies, undervalued
WEAK
🔴 SELL
-40.8% upside
Upside
-40.8%
Quality
14
Belite Bio, IncSector: Healthcare
Industry: Biotechnology
Employees: 41
Belite Bio, Inc, a clinical stage biopharmaceutical drug development company, engages in the research and development of novel therapeutics with unmet medical needs in the United States. Its lead product candidate is Tinlarebant (LBS-008), an orally administered, which is in phase 3 clinical trial as an early intervention for maintaining the health and integrity of retinal tissues in stargardt disease type 1 and geographic atrophy patients. The company also develops LBS-009, an retinol binding protein 4 oral therapy, which is in preclinical development targeting liver disease, including non-alcoholic fatty liver disease, nonalcoholic steatohepatitis, and type 2 diabetes, as well as gout. Belite Bio, Inc was founded in 2016 and is based in San Diego, California. Belite Bio, Inc operates as a subsidiary of Lin Bioscience International Ltd.
BLTE
Latest News
—
Caricamento notizie per BLTE…
stock quote shares BLTE – Belite Bio Inc ADR Stock Price stock today
news today BLTE – Belite Bio Inc ADR stock forecast ,stock prediction 2023 2024 2025
marketwatch BLTE – Belite Bio Inc ADR yahoo finance google finance
stock history BLTE – Belite Bio Inc ADR invest stock market
stock prices BLTE premarket after hours
ticker BLTE fair value insiders trading